GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BSE:BAYN) » Definitions » Change In Receivables

Bayer AG (BSE:BAYN) Change In Receivables : lei-1,531 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Bayer AG Change In Receivables?

Bayer AG's change in receivables for the quarter that ended in Sep. 2024 was lei14,701 Mil. It means Bayer AG's Accounts Receivable declined by lei14,701 Mil from Jun. 2024 to Sep. 2024 .

Bayer AG's change in receivables for the fiscal year that ended in Dec. 2023 was lei3,558 Mil. It means Bayer AG's Accounts Receivable declined by lei3,558 Mil from Dec. 2022 to Dec. 2023 .

Bayer AG's Accounts Receivable for the quarter that ended in Sep. 2024 was lei54,173 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Bayer AG's Days Sales Outstanding for the three months ended in Sep. 2024 was 94.35.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bayer AG's liquidation value for the three months ended in Sep. 2024 was lei-292,810 Mil.

Bayer AG Change In Receivables Historical Data

The historical data trend for Bayer AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Change In Receivables Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.67 4,003.95 -326.41 1,349.45 3,558.16

Bayer AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16,385.09 5,055.79 -24,753.82 3,466.32 14,700.87

Bayer AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei-1,531 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG  (BSE:BAYN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bayer AG's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=54172.986/52391.222*91
=94.35

2. In Ben Graham's calculation of liquidation value, Bayer AG's accounts receivable are only considered to be worth 75% of book value:

Bayer AG's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=33317.411-400776.027+0.75 * 54172.986+0.5 * 68038.159
=-292,810

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bayer AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Bayer AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BSE:BAYN) » Definitions » Change In Receivables
Comparable Companies
INFU STAA LMAT COO ZJYL MMSI WST AVTR STVN ALGN LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG XSWX:NOVN LSE:AZN AMGN PFE
Traded in Other Exchanges
BAYZF:USA BAYRY:USA BAY:Poland 1BAYN:Italy BAYER:Hungary 0P6S:UK BAYNd:UK BAYN:Germany BAYN:Bulgaria BAYN:Austria
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Website
https://www.bayer.com
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.